Anlotinib and Sintilimab injection
KEEP-G 04
Phase 2 small_molecule active
Quick answer
Anlotinib and Sintilimab injection for Advanced Hepatocellular Carcinoma is a Phase 2 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Advanced Hepatocellular Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active